EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial

Pedro Cepas-Guillén iD, Amr E Abbas iD, Vicenç Serra, Victoria Vilalta iD, Luis Nombela-Franco iD, Ander Regueiro, Karim M Al-Azizi iD, Ayman Iskander, Lenard Conradi iD, Jessica Forcillo iD, Scott Lilly iD, Álvaro Calabuig iD und 6 weitere

Circulation: Cardiovascular Interventions · 2026-03 · 19 (3)

DOI: 10.1161/circinterventions.125.016255 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-03. Verfasst von Pedro Cepas-Guillén und 17 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Cardiology Department, Laval University, Canada (P.C.-G., S.M., C.G., E.P.-B., P.P., J.R.-C.). Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Insufficiency, Aortic Valve Stenosis, Balloon Valvuloplasty. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Data comparing valve systems in the valve-in-valve transcatheter aortic valve replacement (TAVR) field have been obtained from retrospective studies. This prespecified secondary analysis of the LYTEN randomized trial (Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprostheses) aims to compare the 3-year hemodynamic performance and clinical outcomes between balloon-expandable valves (BEV) SAPIEN 3/ULTRA (Edwards Lifesciences) and self-expanding valves (SEV) Evolut R/PRO/PRO+ (Medtronic) in valve-in-valve TAVR. METHODS: Patients with a failed small (≤23 mm) surgical valve undergoing valve-in-valve TAVR were randomized to receive a SEV or a BEV. Patients had a clinical and valve hemodynamic (Doppler echocardiography) evaluation at 3-year follow-up. Study outcomes were defined according to VARC (Valve Academic Research Consortium)-2/VARC-3 criteria. Intended performance of the valve was defined as mean gradient

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve InsufficiencyAortic Valve StenosisBalloon ValvuloplastyBioprosthesisHeart Valve ProsthesisProsthesis FailureTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleHemodynamicsProsthesis DesignRecovery of FunctionRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

bioprosthesisheart failureheart valve prosthesishemodynamicstranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Cardiology Department, Laval University, Canada (P.C.-G., S.M., C.G., E.P.-B., P.P., J.R.-C.).
  • Clinic Cardiovascular Institute, Hospital Clinic de Barcelona, Cardiology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain (P.C.-G., A.R., J.R.-C.).
  • Corewell Health East, Cardiology Department, William Beaumont University Hospital, Royal Oak, MI (A.E.A.).
  • Hospital Universitari Vall d'Hebron, Cardiology Department, Barcelona, Spain (V.S., A.C.).
  • Hospital Universitari Germans Trias i Pujol, Badalona, Spain (V.V., E.F.-N.).
  • Cardiovascular Institute, Hospital Clínico San Carlos, Cardiology Department, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain (L.N.-F.).

ORCID-Profile: Pedro Cepas-Guillén, Amr E Abbas, Victoria Vilalta, Luis Nombela-Franco, Karim M Al-Azizi, Lenard Conradi, Jessica Forcillo, Scott Lilly, Álvaro Calabuig, Eduard Fernandez-Nofrerias, Siamak Mohammadi, Carlos Giuliani, Emilie Pelletier-Beaumont, Philippe Pibarot, Josep Rodés-Cabau

Zitieren

APA

Cepas-Guillén, P., Abbas, A. E., Serra, V., Vilalta, V., Nombela-Franco, L., Regueiro, A., Al-Azizi, K. M., Iskander, A., Conradi, L., Forcillo, J., Lilly, S., Calabuig, Á., Fernandez-Nofrerias, E., Mohammadi, S., Giuliani, C., Pelletier-Beaumont, E., Pibarot, P., & Rodés-Cabau, J. (2026). Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial. Circulation: Cardiovascular Interventions, 19(3). https://doi.org/10.1161/circinterventions.125.016255

Vancouver

Cepas-Guillén P, Abbas AE, Serra V, Vilalta V, Nombela-Franco L, Regueiro A, et al. Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial. Circulation: Cardiovascular Interventions. 2026;19(3). doi:10.1161/circinterventions.125.016255

BibTeX
@article{CepasGuilln2026,
  author = {Cepas-Guillén, Pedro and Abbas, Amr E and Serra, Vicenç and Vilalta, Victoria and Nombela-Franco, Luis and Regueiro, Ander and Al-Azizi, Karim M and Iskander, Ayman and Conradi, Lenard and Forcillo, Jessica and Lilly, Scott and Calabuig, Álvaro and Fernandez-Nofrerias, Eduard and Mohammadi, Siamak and Giuliani, Carlos and Pelletier-Beaumont, Emilie and Pibarot, Philippe and Rodés-Cabau, Josep},
  title = {Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {3},
  doi = {10.1161/circinterventions.125.016255}
}
Kostenlos starten →